Weight Change Among Users of Three Progestin-Only Methods of Contraception Over a 12-Month Time Period

Completed

Conditions studied: Weight Change

In brief

The purpose of this study is to learn whether women who use progestin-only methods of birth control such as the contraceptive implant (Implanon), the levonorgestral-releasing IUS (Mirena), or depot medroxyprogesterone acetate(DMPA) will experience weight change compared to women using the non-hormonal copper IUC (ParaGard). The investigators primary hypothesis is that users of DMPA will gain excess weight and increase their BMI above the copper-IUC users; secondarily, the investigators will compare users' data in the LNG-IUC and ENG implant groups to the copper-IUC group.

Key facts

Study ID

NCT01592058

Run by

Washington University School of Medicine

People needed

427

Starts

2010-06-01

Expected to finish

2012-05-01

Last updated by the study team

2012-07-31

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Patients enrolled in CHOICE between the ages of 18 and 45 who consented to future studies
• Chose levonorgestrel-releasing IUD, copper IUD, the implant, or DMPA as their CHOICE baseline method
• Has baseline height and weight data collected from the on-campus enrollment site
• Able to come back to the on-campus enrollment site for consent process and enrollment activities

You may not qualify if…

• Recent history of DMPA use before starting their baseline CHOICE method
• Used current method for less than 11 months or more than 12 months and three weeks

Where it is running

• Washington University School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.